TAFNEXT

Tenofovir Alafenamide 25mg Tablet

Enquire NOW!




Description

Description

Tafnext 25mg

Composition: Tenofovir Alafenamide—25 mg

Classification: Hepatitis B Medicine

Tafnext: Next Generation Hepatitis B Medicine

Tafnext is widely accepted and highly prescribed by doctors for HBV control in chronic hepatitis B infections.

Aprazer Healthcare: Leading Hepatology Medicine Manufacturer and Exporter

Aprazer Healthcare is advancing hepatitis B treatment by manufacturing an affordable range of hepatitis B medicines, both antivirals and antiretrovirals.

  • • International Quality Standards – WHO-GMP certified
  • • Affordable life–saving medicines
  • • Available in 20 countries

What is Tafnext?

It is an antiretroviral drug that is used against chronic Hepatitis B and HIV-1 infections.

Uses of Tafnext

  • • Chronic Hepatitis B
  • • HIV-1 infections

Benefits

  • • Significant viral suppression
  • • Fewer side-effects
  • • Lesser kidney side-effects
  • • Improved liver functions
  • • Better bone mineral density

How does it work?

It gets attached to the virus, mimics its DNA bases and terminates the chain elongation process, causing virus cell death.

Common Side Effects

  • • Nausea
  • • Dizziness
  • • Headache
  • • Digestive issues
  • • Tiredness
  • • Diarrhea
  • • Abdominal pain

Serious Side Effects

  • • Lactic Acidosis – unusual pain, breathing issues, irregular heartbeats, abdominal pain
  • • Irregular heartbeat – Arrhythmia
  • • Trouble breathing
  • • Enlarged fatty liver
  • • Severely low phosphate levels cause muscle weakness

Precautions

To be used cautiously in patients with:

  • • Kidney disorders
  • • HIV co-infections
  • • Liver transplant
  • • Elderly patients

Contraindications

  • • Not to be used if any previous allergy or hypersensitivity to Tenofovir or any excipients
  • • Breastfeeding mothers
  • • Pregnant women
  • • It Should not be used as monotherapy for HIV patients

Warning

To be used under medical prescription only

Important Safety and Monitoring Information

  • • Regular monitoring of liver function, renal function, and bone density
  • • Screen for viral load and HIV infections before treatment initiation
  • • Hepatitis B flares may occur if the medicine is abruptly discontinued
Download Product PDF Attachment